Analysis InMed Pharmaceuticals Inc. (INM)
6/4/2024
Analysis of InMed Pharmaceuticals Inc. (INM)
InMed Pharmaceuticals Inc. is showing some interesting price movements and technical indicators based on the provided data.1. Price Movement:
- The closing price has been fluctuating between 0.28000 and 0.35300 over the past few days.
- There seems to be some volatility in the price, with both highs and lows being recorded.
2. Technical Indicators:
- RSI Indicator: The Relative Strength Index (RSI) values are mostly in the range of 45 to 65, indicating moderate price momentum.
- MACD Indicator: The Moving Average Convergence Divergence (MACD) values are positive, suggesting a bullish trend.
- Moving Averages: The Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) are all showing slight variations, indicating potential price trends.
3. Overall Analysis:
- The RSI values suggest that the stock is neither overbought nor oversold, indicating a balanced market sentiment.
- The positive MACD values and moving averages indicate a potential bullish trend in the short term.
- Traders and investors may want to monitor the price movements closely to identify potential entry or exit points.
Please note that this analysis is based on the provided data and should be supplemented with additional research before making any investment decisions.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has a strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and the most recent quarter reported is March 2024. The company shows good returns on assets and equity.
In terms of stock statistics, there is a low short ratio and a significant percentage of shares held by institutions. The stock has a beta of 1.264 and has been trading within a range between a fifty-two-week low and high.
Valuation metrics show a relatively high PEG ratio and forward PE ratio. The company's market capitalization and enterprise value are substantial, with high price to book and price to sales ratios. The enterprise value to EBITDA and revenue ratios are also notable.
The stock price summary includes moving averages, a 52-week price range, and beta value.
Lastly, the dividends and splits information shows the company's dividend dates, split history, and dividend yield metrics. The company has a consistent dividend payout and yield.
Income statement 💸
These are the revenue figures. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a potential need for cost management.
3. The gross profit margin has remained relatively stable over the years, indicating efficient cost control measures.
4. Operating income has shown a positive trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
5. Net income has also been increasing consistently, reaching $97 billion in 2023 from $57.4 billion in 2020.
6. Earnings per share (EPS) have shown a slight fluctuation but have generally been on an upward trajectory.
7. The company has been able to maintain a healthy EBITDA margin over the years, indicating operational efficiency.
8. Overall, the financial performance of the company in terms of revenue and profitability has been positive and improving.
Revenue estimate
Based on analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company over the specified periods.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is 5.2%.
3. Current Year: The estimated growth rate for the current year is 7.6%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 9.7%.
These estimates suggest that the company has been experiencing strong growth in the past, but analysts expect the growth rate to moderate slightly in the coming years, although it is still expected to be healthy.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median and average price above the current price. However, there is a wide range between the low and high forecasts, indicating some uncertainty in the predictions. Investors should consider these factors when making decisions about buying or selling the security.
Balance Sheet
These are balance sheets. Here are the conclusions based on the data provided:1. The total assets have been increasing over the years, reaching the highest value of $365,725,000,000 in 2018.
2. Current assets fluctuate from year to year, with the highest value of $162,819,000,000 in 2019.
3. Non-current assets have also been increasing steadily, with the highest value of $234,386,000,000 in 2018.
4. Total liabilities have been increasing over the years, reaching the highest value of $290,437,000,000 in 2023.
5. Shareholders' equity has been fluctuating, with the highest value of $107,147,000,000 in 2018.
6. The company has been relying more on non-current assets to support its operations, as seen in the increasing trend of non-current assets compared to current assets.
7. The company has been financing its operations through a combination of liabilities and shareholders' equity, with liabilities forming a significant portion of the total financing.
8. The company's retained earnings have been negative in some years, indicating that the company has experienced losses in those periods.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has been consistently higher than free cash flow, indicating that the company is generating sufficient cash from its core operations.
3. The company has been paying a significant amount in income taxes each year, with the highest amount paid in 2021.
4. The end cash position has also been fluctuating, with the highest value in 2020 and the lowest in 2022.
5. The company has been repurchasing common stock and paying dividends, which has had an impact on its financing activities.
6. Investing activities have also varied, with significant amounts spent on the sale and purchase of investments in different years.
7. Depreciation and stock-based compensation have been consistent components of the operating activities each year.
8. Interest paid has fluctuated over the years, with a noticeable increase in 2023.
9. The company has been issuing and paying off long-term debt, as well as short-term debt, as part of its financing activities.
10. Overall, the company's cash flow statement reflects fluctuations in various financial activities over the years, indicating a dynamic financial performance.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share (EPS), we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago, as projected by 27 analysts.
2. Looking ahead to the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, ranging from a low estimate of $1.33 to a high estimate of $1.51. This is also an increase from the EPS of $1.35 in the corresponding quarter last year, based on projections from 26 analysts.
3. For the current fiscal year ending on September 30, 2024, the average EPS estimate is $6.10, with a low estimate of $5.95 and a high estimate of $6.41. This reflects growth compared to the EPS of $5.67 for the previous fiscal year, as forecasted by 40 analysts.
4. Looking further ahead to the next fiscal year ending on September 30, 2025, the average EPS estimate is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This indicates a potential increase from the EPS of $6.10 in the current fiscal year, as estimated by 40 analysts.
Overall, the analysts' estimates suggest a positive outlook for the company's earnings per share, showing growth trends in both the quarterly and annual performance over the specified periods.
MACD of INM
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
